D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 52 Citations 17,013 98 World Ranking 1879 National Ranking 58

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

Jacques Pépin spends much of his time researching Internal medicine, Clostridium difficile, Bezlotoxumab, Incidence and Surgery. His Internal medicine study incorporates themes from Clindamycin and Immunology. Jacques Pépin has included themes like Infection control, Intensive care medicine, Antibacterial agent and Metronidazole in his Clostridium difficile study.

His Infection control research includes themes of Epidemiology, Fidaxomicin, Antimicrobial stewardship, Antibiotic-associated diarrhea and Surotomycin. His study on Bezlotoxumab also encompasses disciplines like

  • Clostridium Difficile Colitis and related Pseudomembranous colitis,
  • Proportional hazards model most often made with reference to Perforation. His research in Incidence tackles topics such as Odds ratio which are related to areas like Biopsy, Bacteremia, Antibiotic prophylaxis and Ciprofloxacin.

His most cited work include:

  • Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) (2506 citations)
  • Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe (1244 citations)
  • Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity (1000 citations)

What are the main themes of his work throughout his whole career to date?

Jacques Pépin focuses on Internal medicine, Immunology, Virology, Clostridium difficile and Trypanosomiasis. In his study, Odds ratio is inextricably linked to Surgery, which falls within the broad field of Internal medicine. His work deals with themes such as Cerebrospinal fluid, Epidemiology, Acquired immunodeficiency syndrome, Sexually transmitted disease and Sex organ, which intersect with Immunology.

His Virology study combines topics in areas such as Serology and Genotype. The various areas that Jacques Pépin examines in his Clostridium difficile study include Bezlotoxumab, Vancomycin, Antibacterial agent and Intensive care medicine. In general Trypanosomiasis, his work in African trypanosomiasis, Melarsoprol and Trypanosoma brucei gambiense is often linked to Eflornithine linking many areas of study.

He most often published in these fields:

  • Internal medicine (36.36%)
  • Immunology (21.39%)
  • Virology (17.65%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (36.36%)
  • Clostridium difficile (16.04%)
  • Virology (17.65%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Clostridium difficile, Virology, Surgery and Prospective cohort study. His study in the field of Cohort, Mortality rate, Odds ratio and Incidence is also linked to topics like Prostate biopsy. The Clostridium difficile study combines topics in areas such as Vancomycin and Intensive care unit, Intensive care medicine.

As part of the same scientific family, Jacques Pépin usually focuses on Vancomycin, concentrating on Metronidazole and intersecting with Retrospective cohort study and Cohort study. The concepts of his Virology study are interwoven with issues in Sex organ and Genotype. His work in Surgery addresses issues such as External validation, which are connected to fields such as Medical physics.

Between 2014 and 2021, his most popular works were:

  • Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection (84 citations)
  • Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections (54 citations)
  • Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort (35 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

Internal medicine, Clostridium difficile, Hepatitis C virus, Virology and Sanger sequencing are his primary areas of study. His research on Internal medicine frequently links to adjacent areas such as Toxic megacolon. His studies in Clostridium difficile integrate themes in fields like Perforation, Surgery, Vital signs, Intensive care medicine and Vancomycin.

He has researched Intensive care medicine in several fields, including Bezlotoxumab, Incidence and Metronidazole. As a member of one scientific family, Jacques Pépin mostly works in the field of Virology, focusing on Serology and, on occasion, Epidemiology, Blood transfusion, Pandemic, Tuberculosis and Intramuscular injection. His Sanger sequencing study combines topics from a wide range of disciplines, such as Polymerase chain reaction and Genotype.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

Stuart H. Cohen;Dale N. Gerding;Stuart Johnson;Ciaran P. Kelly.
Infection Control and Hospital Epidemiology (2010)

4231 Citations

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

Michel Warny;Jacques Pepin;Aiqi Fang;George Killgore.
The Lancet (2005)

1699 Citations

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

Jacques Pépin;Louis Valiquette;Marie-Eve Alary;Philippe Villemure.
Canadian Medical Association Journal (2004)

1371 Citations

Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile–Associated Diarrhea: A Cohort Study during an Epidemic in Quebec

Jacques Pépin;Nathalie Saheb;Marie-Andrée Coulombe;Marie-Eve Alary.
Clinical Infectious Diseases (2005)

1201 Citations

Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec

Jacques Pépin;Louis Valiquette;Benoit Cossette.
Canadian Medical Association Journal (2005)

780 Citations

Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada

Jacques Pépin;Marie-Eve Alary;Louis Valiquette;Evelyne Raiche.
Clinical Infectious Diseases (2005)

709 Citations

The early spread and epidemic ignition of HIV-1 in human populations

Nuno Rodrigues Faria;Andrew Rambaut;Marc A Suchard;Guy Baele.
Science (2014)

668 Citations

Comparison of Seven Techniques for Typing International Epidemic Strains of Clostridium difficile: Restriction Endonuclease Analysis, Pulsed-Field Gel Electrophoresis, PCR-Ribotyping, Multilocus Sequence Typing, Multilocus Variable-Number Tandem-Repeat Analysis, Amplified Fragment Length Polymorphism, and Surface Layer Protein A Gene Sequence Typing

G. Killgore;A. Thompson;S. Johnson;J. Brazier.
Journal of Clinical Microbiology (2008)

482 Citations

Impact of a Reduction in the Use of High-Risk Antibiotics on the Course of an Epidemic of Clostridium difficile-Associated Disease Caused by the Hypervirulent NAP1/027 Strain

Louis Valiquette;Benoit Cossette;Marie-Pierre Garant;Hassan Diab.
Clinical Infectious Diseases (2007)

425 Citations

The treatment of human African trypanosomiasis.

Pépin J;Milord F.
Advances in Parasitology (1994)

422 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jacques Pépin

Dale N. Gerding

Dale N. Gerding

Veterans Health Administration

Publications: 132

Mark H. Wilcox

Mark H. Wilcox

University of Leeds

Publications: 118

Ed J. Kuijper

Ed J. Kuijper

Leiden University Medical Center

Publications: 87

Stuart Johnson

Stuart Johnson

Loyola University Medical Center

Publications: 84

Erik R. Dubberke

Erik R. Dubberke

Washington University in St. Louis

Publications: 82

Curtis J. Donskey

Curtis J. Donskey

Louis Stokes Cleveland VA Medical Center

Publications: 67

Kevin W. Garey

Kevin W. Garey

University of Houston

Publications: 64

Thomas V. Riley

Thomas V. Riley

Edith Cowan University

Publications: 62

Ciaran P. Kelly

Ciaran P. Kelly

Beth Israel Deaconess Medical Center

Publications: 54

Herbert L. DuPont

Herbert L. DuPont

The University of Texas Health Science Center at Houston

Publications: 51

Vincent B. Young

Vincent B. Young

University of Michigan–Ann Arbor

Publications: 43

Derrick W. Crook

Derrick W. Crook

University of Oxford

Publications: 40

Emilio Bouza

Emilio Bouza

Hospital General Universitario Gregorio Marañón

Publications: 35

Michael P. Barrett

Michael P. Barrett

University of Glasgow

Publications: 31

Philippe Büscher

Philippe Büscher

Institute of Tropical Medicine Antwerp

Publications: 31

Thomas J. Louie

Thomas J. Louie

University of Calgary

Publications: 30

Trending Scientists

Thomas Lux

Thomas Lux

Kiel University

Yakov Pesin

Yakov Pesin

Pennsylvania State University

Jun-Yan Zhu

Jun-Yan Zhu

Carnegie Mellon University

Sumei Sun

Sumei Sun

Agency for Science, Technology and Research

Isabel Gràcia

Isabel Gràcia

Spanish National Research Council

V. V. Dodonov

V. V. Dodonov

University of Brasília

Myung S. Jhon

Myung S. Jhon

Carnegie Mellon University

Richard P. Oliver

Richard P. Oliver

Curtin University

Karl Schellander

Karl Schellander

University of Bonn

James Haile

James Haile

University of Copenhagen

J. H. J. van der Werf

J. H. J. van der Werf

University of New England

Koichiro Takeshige

Koichiro Takeshige

Kyushu University

Dongchon Kang

Dongchon Kang

Kyushu University

Ronald Dubner

Ronald Dubner

University of Maryland, Baltimore

Peter A. Bandettini

Peter A. Bandettini

National Institutes of Health

Gary C. Curhan

Gary C. Curhan

Brigham and Women's Hospital

Something went wrong. Please try again later.